Association of Serum Lipoprotein-Associated Phospholipase A2 Level with Nonalcoholic Fatty Liver Disease


COLAK Y. , SENATES E. , OZTURK O., DOGANAY H. L. , Coskunpinar E., Oltulu Y. M. , et al.

METABOLIC SYNDROME AND RELATED DISORDERS, cilt.10, ss.103-109, 2012

  • Cilt numarası: 10 Konu: 2
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1089/met.2011.0111
  • Dergi Adı: METABOLIC SYNDROME AND RELATED DISORDERS
  • Sayfa Sayısı: ss.103-109

Özet

Background: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is one of the most common causes of chronic liver disease, worldwide. Lipoprotein-associated phospholipase A2 (Lp-PLA2) was recently characterized as a novel inflammatory biomarker that is correlated with several components constituting the metabolic syndrome.